EcoDrugPlus

Matrix Metallopeptidase 12

Ensembl ID : ENSTBEG00000009604
Gene Symbol: MMP12
1 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSTBEG00000009968
Gene Symbol: MMP13
1 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSTBEG00000001037
Gene Symbol: MMP14
1 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSTBEG00000017424
Gene Symbol: MMP3
1 Cross references
493 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSTBEG00000017390
Gene Symbol: MMP7
1 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSTBEG00000015520
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSTBEG00000017662
Gene Symbol: MTOR
1 Cross references
214 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSTBEG00000011266
Gene Symbol: MC4R
1 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSTBEG00000014986
Gene Symbol: MTNR1A
1 Cross references
205 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSTBEG00000003304
Gene Symbol: MME
1 Cross references
236 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSTBEG00000009480
Gene Symbol: METAP2
1 Cross references
215 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSTBEG00000001041
Gene Symbol: MAPT
1 Cross references
255 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).